Back
CytoMed Therapeutics Ltd. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
GDTC
CytoMed Therapeutics Ltd.
Last Price:
$1.44
Seasonality Move:
-6.92%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDTC is experiencing selling pressure, which indicates risk of future bearish movement.
CytoMed Therapeutics Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.55 | Sell |
| 20-day SMA: | 1.67 | Sell |
| 50-day SMA: | 1.95 | Sell |
| 200-day SMA: | 2.1 | Sell |
| 8-day EMA: | 1.55 | Sell |
| 20-day EMA: | 1.66 | Sell |
| 50-day EMA: | 1.82 | Sell |
| 200-day EMA: | 2.06 | Sell |
CytoMed Therapeutics Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 39.58 | Sell |
| Chaikin Money Flow: | -3352 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CytoMed Therapeutics Ltd. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytoMed Therapeutics Ltd. Stock
Is CytoMed Therapeutics Ltd. Stock a Buy?
-
CytoMed Therapeutics Ltd. share price is 1.53 while GDTC 8-day simple moving average is 1.55, which is a Sell signal.
-
The stock price of GDTC is 1.53 while CytoMed Therapeutics Ltd. 20-day SMA is 1.67, which makes it a Sell.
-
CytoMed Therapeutics Ltd. 50-day simple moving average is 1.95 while GDTC share price is 1.53, making it a Sell technically.
-
GDTC stock price is 1.53 and CytoMed Therapeutics Ltd. 200-day simple moving average is 2.10, creating a Sell signal.
GDTC Technical Analysis vs Fundamental Analysis
Sell
26
CytoMed Therapeutics Ltd. (GDTC)
is a Sell
Is CytoMed Therapeutics Ltd. a Buy or a Sell?
-
CytoMed Therapeutics Ltd. stock is rated a SellThe current CytoMed Therapeutics Ltd. [GDTC] share price is $1.53. The Score for GDTC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
CytoMed Therapeutics Ltd. Stock Info
Market Cap:
18M
Price in USD:
1.53
Share Volume:
13.4K
CytoMed Therapeutics Ltd. 52-Week Range
52-Week High:
4.05
52-Week Low:
1.38
Sell
26
CytoMed Therapeutics Ltd. (GDTC)
is a Sell
CytoMed Therapeutics Ltd. Share Price Forecast
-
What is the CytoMed Therapeutics Ltd. stock price today?The CytoMed Therapeutics Ltd. stock price is 1.53 USD today.
-
Will GDTC stock go up or go down?CytoMed Therapeutics Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is CytoMed Therapeutics Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytoMed Therapeutics Ltd. is overvalued.
Is CytoMed Therapeutics Ltd. Stock a Buy?
-
CytoMed Therapeutics Ltd. share price is 1.53 while GDTC 8-day exponential moving average is 1.55, which is a Sell signal.
-
The stock price of GDTC is 1.53 while CytoMed Therapeutics Ltd. 20-day EMA is 1.66, which makes it a Sell.
-
CytoMed Therapeutics Ltd. 50-day exponential moving average is 1.82 while GDTC share price is 1.53, making it a Sell technically.
-
GDTC stock price is 1.53 and CytoMed Therapeutics Ltd. 200-day simple moving average is 2.06, creating a Sell signal.
Fundamental Analysis of CytoMed Therapeutics Ltd.
Is CytoMed Therapeutics Ltd. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.00 per share.
Technical Analysis of CytoMed Therapeutics Ltd.
Should I short CytoMed Therapeutics Ltd. stock?
-
GDTC Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting CytoMed Therapeutics Ltd. is a Sell
-
CytoMed Therapeutics Ltd. Relative Strength Index (RSI) is 39.58, which suggest CytoMed Therapeutics Ltd. is oversold
-
The Bollinger Bands (25) for CytoMed Therapeutics Ltd. is ( - ), which suggest CytoMed Therapeutics Ltd. is a Buy
-
The Bollinger Bands (100) for CytoMed Therapeutics Ltd. is ( - ), which suggest CytoMed Therapeutics Ltd. is a Buy
* CytoMed Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.